Interleukin‐1β and the interleukin‐1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat
- 1 March 1998
- journal article
- research article
- Published by Wiley in European Journal of Neuroscience
- Vol. 10 (3) , 1188-1195
- https://doi.org/10.1046/j.1460-9568.1998.00136.x
Abstract
The cytokine interleukin‐1 (IL‐1) has been implicated in ischaemic, traumatic and excitotoxic brain damage. The results presented here reveal novel actions of IL‐1 in the striatum which markedly exac...Keywords
This publication has 45 references indexed in Scilit:
- Functional consequences of retrograde axonal transport of receptor-bound neurotensinTrends in Pharmacological Sciences, 1995
- Interleukin-1 as a Pathogenetic Mediator of Ischemic Brain Damage in RatsStroke, 1995
- NBQX prevents contralateral but not ipsilateral seizure-induced cytotoxicity of kainate but not AMPA-reversal at high doses of NBQXNeuroReport, 1994
- Quisqualate Injection into the Nucleus Basalis Magnocellularis Produces Seizure-Related Brain Damage That Is Prevented by MK-801Experimental Neurology, 1994
- Interleukin-1 beta mRNA expression in ischemic rat cortex.Stroke, 1993
- Brain injury and protective effects of hypothermia using triphenyltetrazolium chloride in neonatal ratPediatric Neurology, 1993
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Convulsants induce interleukin-1β messenger RNA in rat brainBiochemical and Biophysical Research Communications, 1990
- Anatomical organization of excitatory amino acid receptors and their pathwaysTrends in Neurosciences, 1987
- Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.Stroke, 1986